Drug intelligence / Profile preview

digestive tract mucosal protective adhesive

Development stage: Preclinical
Lead developer: Yingjian Biological Technology
Modality: Device-based Delivery → Drug Delivery Systems
Administration: Topical

Overview

Digestive tract mucosal protective adhesive is a medical device designed to cover and protect wound surfaces within the digestive tract. It is being investigated for its efficacy and safety in clinical applications, specifically for treating gastric ulcers that occur after endoscopic submucosal dissection (ESD) surgery. The adhesive forms a physical barrier to aid in the healing process and prevent further damage to the mucosa.

Other names: 消化道保护胶

Beyond the preview

Go deeper on digestive tract mucosal protective adhesive.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on digestive tract mucosal protective adhesive.

Explore the full profile